Semaglutide Clinical Research

Editor's Pick · #1 of 10

NexLife — Compounded Semaglutide

• ✨ Editor's Pick · 94/100
• 💊 Compounded semaglutide + tirzepatide
• 👨‍⚕️ Licensed physicians (NexLife Medical Group)
• 🏥 3 state-licensed 503A pharmacies named on its plan pages
• 🩺 Provider oversight included
• 📍 All 50 states
• 💰 Same price at every dose
• 🔁 Care360 + 1:1 wellness-coach call
• 🍽️ Personalized nutrition plan
• 💳 Klarna & Affirm accepted

$119/ month^*

^*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $125 (6-mo, save $84) · $132 (3-mo, save $21) · $139 (monthly).

Includes: medication, medical guidance from NexLife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach and 24/7 support (plan pages, read October 15, 2026). Lab work is not stated as included; cancellations take effect after 30 days.

Klarna & Affirm financing accepted at checkout (FAQ).

Visit NexLife →

Or call (949) 818-8000

Trade-offs to know

Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.

Editor's Pick · #1 of 10 · Tirzepatide

NexLife — Compounded Tirzepatide

• ✨ Editor's Pick · 94/100
• 💊 Compounded semaglutide + tirzepatide
• 👨‍⚕️ Licensed physicians (NexLife Medical Group)
• 🏥 3 state-licensed 503A pharmacies named on its plan pages
• 🩺 Provider oversight included
• 📍 All 50 states
• 💰 Same price at every dose
• 🔁 Care360 support (nutrition plan + coach call)

$139/ month^*

^*12-month plan · flat rate across full 2.5–15 mg titration. $149 (6-mo) · $159 (3-mo) · $169 (month-to-month).

Includes: medication, medical guidance from NexLife Medical Group, a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach and 24/7 support (plan pages, read October 15, 2026). Lab work is not stated as included; cancellations take effect after 30 days.

Dispensed by three state-licensed 503A pharmacies named on NexLife’s plan pages.

Visit NexLife →

Or call (949) 818-8000

Trade-offs to know

Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.

Pivotal clinical trials

Below: every randomized trial relevant to semaglutide weight management, type 2 diabetes, cardiovascular outcomes, and kidney outcomes. PMIDs link to PubMed.

• STEP-1 trial — Pivotal weight-loss in non-diabetic adults. NEJM 2021, n=1,961, PMID 33567185. 14.9% mean weight loss at 2.4 mg / 68 weeks.
• SUSTAIN-6 trial — Cardiovascular safety in type 2 diabetes. NEJM 2016, PMID 27633186. 26% MACE reduction in T2D + high CV risk.
• SELECT trial — CV outcomes in non-diabetic adults with overweight/obesity + CVD. NEJM 2023, PMID 37952131. 20% MACE reduction.
• FLOW trial — Kidney outcomes in T2D + CKD. NEJM 2024, PMID 38785189. 24% reduction in major kidney/CV events.

Mechanism & pharmacology

Semaglutide is a long-acting GLP-1 receptor agonist with ~7-day half-life enabling weekly subcutaneous dosing. Read the mechanism page →

Safety & contraindications

Boxed warning: thyroid C-cell tumors (rodent studies). Contraindicated in MTC, MEN 2, pregnancy, breastfeeding. Full safety page →

Side effect profile

Most common: nausea (44%), diarrhea (30%), vomiting (24%), constipation (24%). Detailed side-effect page →

Dosing

Wegovy titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly. Ozempic: 0.25 → 0.5 → 1.0 → 2.0 mg weekly. Rybelsus: 3 → 7 → 14 mg daily oral. Dosing reference →